Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Peripheral Vascular Interventions

NCT04513613 is registered in ClinicalTrials.gov with Siemens Healthineers Endovascular Robotics, Inc. as lead sponsor.

NCT NCT04513613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Peripheral Vascular Interventions
Lead sponsor
Siemens Healthineers Endovascular Robotics, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
January 31, 2022
Completion date
January 31, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery diseases, peripheral arterial disease, peripheral vascular diseases, renal artery disease